BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8831727)

  • 1. Molecular structure and antioxidant specificity of purpurogallin in three types of human cardiovascular cells.
    Wu TW; Zeng LH; Wu J; Fung KP; Weisel RD; Hempel A; Camerman N
    Biochem Pharmacol; 1996 Oct; 52(7):1073-80. PubMed ID: 8831727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative cytoprotection of cultured corneal endothelial cells by water-soluble antioxidants against free-radical damage.
    Zeng LH; Rootman DS; Fung KP; Wu TW
    Cornea; 1995 Sep; 14(5):509-14. PubMed ID: 8536465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purpurogallin is a more powerful protector of kidney cells than Trolox and allopurinol.
    Zeng LH; Wu TW
    Biochem Cell Biol; 1992 Aug; 70(8):684-90. PubMed ID: 1476704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morin: a wood pigment that protects three types of human cells in the cardiovascular system against oxyradical damage.
    Wu TW; Zeng LH; Wu J; Fung KP
    Biochem Pharmacol; 1994 Mar; 47(6):1099-103. PubMed ID: 8147911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purpurogallin protects both ventricular myocytes and aortic endothelial cells of rats against oxyradical damage.
    Wu TW; Wu J; Carey D; Zeng LH
    Biochem Cell Biol; 1992 Sep; 70(9):803-9. PubMed ID: 1482557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purpurogallin as an antioxidant protector of human erythrocytes against lysis by peroxyl radicals.
    Sugiyama H; Fung KP; Wu TW
    Life Sci; 1993; 53(4):PL39-43. PubMed ID: 8326817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morin hydrate: a better protector than purpurogallin of corneal endothelial cell damage induced by xanthine oxidase and SIN-1.
    Zeng LH; Rootman DS; Burnstein A; Wu J; Wu TW
    Curr Eye Res; 1998 Feb; 17(2):149-52. PubMed ID: 9523092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purpurogallin--a natural and effective hepatoprotector in vitro and in vivo.
    Wu TW; Zeng LH; Wu J; Carey D
    Biochem Cell Biol; 1991; 69(10-11):747-50. PubMed ID: 1799443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purpurogallin, a scavenger of polymorphonuclear leukocyte-derived oxyradicals.
    Prasad K; Kapoor R; Lee P
    Mol Cell Biochem; 1994 Oct; 139(1):27-32. PubMed ID: 7854340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morin hydrate protects cultured rat glomerular mesangial cells against oxyradical damage.
    Zeng LH; Fung KP; Wu TW
    Life Sci; 1994; 55(18):PL351-7. PubMed ID: 7934646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Water-soluble antioxidant specificity against free radical injury using cultured human ventricular myocytes and fibroblasts and saphenous vein endothelial cells.
    Mickle DA; Li RK; Weisel RD; Tumiati LC; Wu TW
    J Mol Cell Cardiol; 1990 Nov; 22(11):1297-304. PubMed ID: 2283686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cytoprotective effect of Trolox demonstrated with three types of human cells.
    Wu TW; Hashimoto N; Wu J; Carey D; Li RK; Mickle DA; Weisel RD
    Biochem Cell Biol; 1990 Oct; 68(10):1189-94. PubMed ID: 2268414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purpurogallin inhibits DNA synthesis of murine fibrosarcoma L-929 and human U-87 MG glioblastoma cells in vitro.
    Fung KP; Wu TW; Lui CP
    Chemotherapy; 1996; 42(3):199-205. PubMed ID: 8983887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purpurogallin as a cytoprotector of cultured rabbit corneal endothelium.
    Rootman DS; Bindish R; Zeng LH; Hasany SM; Wu TW
    Can J Ophthalmol; 1994 Oct; 29(5):220-3. PubMed ID: 7859173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purpurogallin: in vivo evidence of a novel and effective cardioprotector.
    Wu TW; Wu J; Zeng LH; Au JX; Carey D; Fung KP
    Life Sci; 1994; 54(2):PL23-8. PubMed ID: 8277814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical syntheses of Trolox conjugates which protect human ventricular myocytes against in situ-generated oxyradicals.
    Zielenski J; Wu TW; Fung KP; Zeng LH; Li RK; Mickle DA; Wu J
    Eur J Pharmacol; 1993 Dec; 248(4):313-8. PubMed ID: 7514137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propyl gallate as a hepatoprotector in vitro and in vivo.
    Wu TW; Fung KP; Zeng LH; Wu J; Nakamura H
    Biochem Pharmacol; 1994 Jul; 48(2):419-22. PubMed ID: 8053938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithospermic acid B as an antioxidant-based protector of cultured ventricular myocytes and aortic endothelial cells of rabbits.
    Fung KP; Wu J; Zeng LH; Wong HN; Lee CM; Hon PM; Chang HM; Wu TW
    Life Sci; 1993; 53(12):PL189-93. PubMed ID: 8395629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of xanthine oxidase by purpurogallin and silymarin group.
    Sheu SY; Lai CH; Chiang HC
    Anticancer Res; 1998; 18(1A):263-7. PubMed ID: 9568088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trolox protects rat hepatocytes against oxyradical damage and the ischemic rat liver from reperfusion injury.
    Wu TW; Hashimoto N; Au JX; Wu J; Mickle DA; Carey D
    Hepatology; 1991 Mar; 13(3):575-80. PubMed ID: 1999327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.